As a result, patients often have to pay out-of-pocket for these products, which can vary widely in price depending on the compounding pharmacy or facility
Studies have also suggested beneficial effects on inflammation and blood vessel function, two factors increasingly recognized as important contributors to cardiovascular disease.[14][18] Instead of targeting a single problem, GLP-1 medicines appear to influence several risk factors at once
Hims & Hers said the new pill starts at $49 per month for five months, and comes with the same active ingredient as Novo Nordisk's Wegovy, which received FDA approval in December and costs $149 for self-pay patients, according to the company's website
These results suggest retatrutide may prompt even greater weight loss than other weight-loss medications, including Zepbound
It also makes several recommendations for systemic reforms to the patent system to counter the influence of financialization that incentivizes patent abuse, as well as healthcare policies to address these inequities and promote affordable access to these life-changing treatments.
& Kassubek, J